nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—HRH1—atherosclerosis	0.494	1	CbGaD
Escitalopram—CYP2C19—Rosuvastatin—atherosclerosis	0.0355	0.123	CbGbCtD
Escitalopram—CYP2C19—Simvastatin—atherosclerosis	0.033	0.114	CbGbCtD
Escitalopram—CYP2C19—Lovastatin—atherosclerosis	0.0323	0.112	CbGbCtD
Escitalopram—CYP2D6—Niacin—atherosclerosis	0.0317	0.11	CbGbCtD
Escitalopram—CYP2D6—Simvastatin—atherosclerosis	0.0251	0.087	CbGbCtD
Escitalopram—CYP2D6—Pravastatin—atherosclerosis	0.0246	0.0852	CbGbCtD
Escitalopram—CYP2D6—Lovastatin—atherosclerosis	0.0246	0.0852	CbGbCtD
Escitalopram—CYP3A4—Rosuvastatin—atherosclerosis	0.0172	0.0595	CbGbCtD
Escitalopram—CYP3A4—Ezetimibe—atherosclerosis	0.0172	0.0595	CbGbCtD
Escitalopram—CYP3A4—Simvastatin—atherosclerosis	0.016	0.0554	CbGbCtD
Escitalopram—CYP3A4—Lovastatin—atherosclerosis	0.0156	0.0542	CbGbCtD
Escitalopram—CYP3A4—Pravastatin—atherosclerosis	0.0156	0.0542	CbGbCtD
Escitalopram—Citalopram—HRH1—atherosclerosis	0.00405	1	CrCbGaD
Escitalopram—Muscle spasms—Simvastatin—atherosclerosis	0.000162	0.000941	CcSEcCtD
Escitalopram—Vertigo—Lovastatin—atherosclerosis	0.000162	0.00094	CcSEcCtD
Escitalopram—Angioedema—Ezetimibe—atherosclerosis	0.000161	0.000938	CcSEcCtD
Escitalopram—Angiopathy—Niacin—atherosclerosis	0.000161	0.000937	CcSEcCtD
Escitalopram—Leukopenia—Lovastatin—atherosclerosis	0.000161	0.000937	CcSEcCtD
Escitalopram—Chills—Niacin—atherosclerosis	0.000159	0.000926	CcSEcCtD
Escitalopram—Malaise—Ezetimibe—atherosclerosis	0.000159	0.000926	CcSEcCtD
Escitalopram—Vision blurred—Simvastatin—atherosclerosis	0.000159	0.000922	CcSEcCtD
Escitalopram—Arrhythmia—Niacin—atherosclerosis	0.000159	0.000922	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000158	0.000918	CcSEcCtD
Escitalopram—Tremor—Simvastatin—atherosclerosis	0.000158	0.000917	CcSEcCtD
Escitalopram—Alopecia—Niacin—atherosclerosis	0.000157	0.000912	CcSEcCtD
Escitalopram—Chills—Pravastatin—atherosclerosis	0.000157	0.000912	CcSEcCtD
Escitalopram—Insomnia—Rosuvastatin—atherosclerosis	0.000157	0.000911	CcSEcCtD
Escitalopram—Ill-defined disorder—Simvastatin—atherosclerosis	0.000156	0.000908	CcSEcCtD
Escitalopram—Arrhythmia—Pravastatin—atherosclerosis	0.000156	0.000908	CcSEcCtD
Escitalopram—Palpitations—Ezetimibe—atherosclerosis	0.000156	0.000907	CcSEcCtD
Escitalopram—Paraesthesia—Rosuvastatin—atherosclerosis	0.000156	0.000905	CcSEcCtD
Escitalopram—Anaemia—Simvastatin—atherosclerosis	0.000156	0.000905	CcSEcCtD
Escitalopram—Malnutrition—Niacin—atherosclerosis	0.000155	0.000899	CcSEcCtD
Escitalopram—Erythema—Niacin—atherosclerosis	0.000155	0.000899	CcSEcCtD
Escitalopram—Alopecia—Pravastatin—atherosclerosis	0.000154	0.000898	CcSEcCtD
Escitalopram—Cough—Ezetimibe—atherosclerosis	0.000154	0.000896	CcSEcCtD
Escitalopram—Angioedema—Simvastatin—atherosclerosis	0.000154	0.000894	CcSEcCtD
Escitalopram—Myalgia—Lovastatin—atherosclerosis	0.000153	0.000891	CcSEcCtD
Escitalopram—Arthralgia—Lovastatin—atherosclerosis	0.000153	0.000891	CcSEcCtD
Escitalopram—Chest pain—Lovastatin—atherosclerosis	0.000153	0.000891	CcSEcCtD
Escitalopram—Anxiety—Lovastatin—atherosclerosis	0.000153	0.000888	CcSEcCtD
Escitalopram—Dyspepsia—Rosuvastatin—atherosclerosis	0.000153	0.000887	CcSEcCtD
Escitalopram—Hypertension—Ezetimibe—atherosclerosis	0.000152	0.000886	CcSEcCtD
Escitalopram—Flatulence—Niacin—atherosclerosis	0.000152	0.000886	CcSEcCtD
Escitalopram—Malaise—Simvastatin—atherosclerosis	0.000152	0.000883	CcSEcCtD
Escitalopram—Tension—Niacin—atherosclerosis	0.000152	0.000882	CcSEcCtD
Escitalopram—Discomfort—Lovastatin—atherosclerosis	0.000151	0.00088	CcSEcCtD
Escitalopram—Vertigo—Simvastatin—atherosclerosis	0.000151	0.000879	CcSEcCtD
Escitalopram—Leukopenia—Simvastatin—atherosclerosis	0.000151	0.000876	CcSEcCtD
Escitalopram—Myalgia—Ezetimibe—atherosclerosis	0.00015	0.000874	CcSEcCtD
Escitalopram—Chest pain—Ezetimibe—atherosclerosis	0.00015	0.000874	CcSEcCtD
Escitalopram—Arthralgia—Ezetimibe—atherosclerosis	0.00015	0.000874	CcSEcCtD
Escitalopram—Nervousness—Niacin—atherosclerosis	0.00015	0.000873	CcSEcCtD
Escitalopram—Flatulence—Pravastatin—atherosclerosis	0.00015	0.000872	CcSEcCtD
Escitalopram—Dry mouth—Lovastatin—atherosclerosis	0.00015	0.000871	CcSEcCtD
Escitalopram—Tension—Pravastatin—atherosclerosis	0.000149	0.000868	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000149	0.000868	CcSEcCtD
Escitalopram—Dysgeusia—Pravastatin—atherosclerosis	0.000149	0.000867	CcSEcCtD
Escitalopram—Muscle spasms—Niacin—atherosclerosis	0.000149	0.000864	CcSEcCtD
Escitalopram—Discomfort—Ezetimibe—atherosclerosis	0.000148	0.000863	CcSEcCtD
Escitalopram—Pain—Rosuvastatin—atherosclerosis	0.000148	0.000862	CcSEcCtD
Escitalopram—Constipation—Rosuvastatin—atherosclerosis	0.000148	0.000862	CcSEcCtD
Escitalopram—Confusional state—Lovastatin—atherosclerosis	0.000148	0.000861	CcSEcCtD
Escitalopram—Nervousness—Pravastatin—atherosclerosis	0.000148	0.000859	CcSEcCtD
Escitalopram—Dry mouth—Ezetimibe—atherosclerosis	0.000147	0.000855	CcSEcCtD
Escitalopram—Anaphylactic shock—Lovastatin—atherosclerosis	0.000147	0.000854	CcSEcCtD
Escitalopram—Muscle spasms—Pravastatin—atherosclerosis	0.000146	0.000851	CcSEcCtD
Escitalopram—Infection—Lovastatin—atherosclerosis	0.000146	0.000848	CcSEcCtD
Escitalopram—Vision blurred—Niacin—atherosclerosis	0.000146	0.000847	CcSEcCtD
Escitalopram—Confusional state—Ezetimibe—atherosclerosis	0.000145	0.000845	CcSEcCtD
Escitalopram—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000144	0.000838	CcSEcCtD
Escitalopram—Thrombocytopenia—Lovastatin—atherosclerosis	0.000144	0.000836	CcSEcCtD
Escitalopram—Vision blurred—Pravastatin—atherosclerosis	0.000143	0.000834	CcSEcCtD
Escitalopram—Arthralgia—Simvastatin—atherosclerosis	0.000143	0.000833	CcSEcCtD
Escitalopram—Chest pain—Simvastatin—atherosclerosis	0.000143	0.000833	CcSEcCtD
Escitalopram—Myalgia—Simvastatin—atherosclerosis	0.000143	0.000833	CcSEcCtD
Escitalopram—Infection—Ezetimibe—atherosclerosis	0.000143	0.000832	CcSEcCtD
Escitalopram—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000143	0.00083	CcSEcCtD
Escitalopram—Anxiety—Simvastatin—atherosclerosis	0.000143	0.00083	CcSEcCtD
Escitalopram—Tremor—Pravastatin—atherosclerosis	0.000143	0.000829	CcSEcCtD
Escitalopram—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000142	0.000824	CcSEcCtD
Escitalopram—Discomfort—Simvastatin—atherosclerosis	0.000142	0.000823	CcSEcCtD
Escitalopram—Nervous system disorder—Ezetimibe—atherosclerosis	0.000141	0.000821	CcSEcCtD
Escitalopram—Angioedema—Niacin—atherosclerosis	0.000141	0.000821	CcSEcCtD
Escitalopram—Ill-defined disorder—Pravastatin—atherosclerosis	0.000141	0.000821	CcSEcCtD
Escitalopram—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000141	0.00082	CcSEcCtD
Escitalopram—Anaemia—Pravastatin—atherosclerosis	0.000141	0.000818	CcSEcCtD
Escitalopram—Anorexia—Lovastatin—atherosclerosis	0.00014	0.000814	CcSEcCtD
Escitalopram—Skin disorder—Ezetimibe—atherosclerosis	0.00014	0.000814	CcSEcCtD
Escitalopram—Angioedema—Pravastatin—atherosclerosis	0.000139	0.000809	CcSEcCtD
Escitalopram—Vertigo—Niacin—atherosclerosis	0.000139	0.000807	CcSEcCtD
Escitalopram—Syncope—Niacin—atherosclerosis	0.000139	0.000806	CcSEcCtD
Escitalopram—Confusional state—Simvastatin—atherosclerosis	0.000138	0.000805	CcSEcCtD
Escitalopram—Leukopenia—Niacin—atherosclerosis	0.000138	0.000804	CcSEcCtD
Escitalopram—Urticaria—Rosuvastatin—atherosclerosis	0.000138	0.000801	CcSEcCtD
Escitalopram—Oedema—Simvastatin—atherosclerosis	0.000137	0.000799	CcSEcCtD
Escitalopram—Anaphylactic shock—Simvastatin—atherosclerosis	0.000137	0.000799	CcSEcCtD
Escitalopram—Malaise—Pravastatin—atherosclerosis	0.000137	0.000798	CcSEcCtD
Escitalopram—Abdominal pain—Rosuvastatin—atherosclerosis	0.000137	0.000797	CcSEcCtD
Escitalopram—Vertigo—Pravastatin—atherosclerosis	0.000137	0.000795	CcSEcCtD
Escitalopram—Palpitations—Niacin—atherosclerosis	0.000137	0.000794	CcSEcCtD
Escitalopram—Infection—Simvastatin—atherosclerosis	0.000136	0.000794	CcSEcCtD
Escitalopram—Leukopenia—Pravastatin—atherosclerosis	0.000136	0.000792	CcSEcCtD
Escitalopram—Loss of consciousness—Niacin—atherosclerosis	0.000136	0.00079	CcSEcCtD
Escitalopram—Cough—Niacin—atherosclerosis	0.000135	0.000784	CcSEcCtD
Escitalopram—Thrombocytopenia—Simvastatin—atherosclerosis	0.000134	0.000782	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000134	0.000778	CcSEcCtD
Escitalopram—Insomnia—Lovastatin—atherosclerosis	0.000133	0.000772	CcSEcCtD
Escitalopram—Cough—Pravastatin—atherosclerosis	0.000133	0.000772	CcSEcCtD
Escitalopram—Paraesthesia—Lovastatin—atherosclerosis	0.000132	0.000767	CcSEcCtD
Escitalopram—Myalgia—Niacin—atherosclerosis	0.000132	0.000765	CcSEcCtD
Escitalopram—Arthralgia—Niacin—atherosclerosis	0.000132	0.000765	CcSEcCtD
Escitalopram—Hypertension—Pravastatin—atherosclerosis	0.000131	0.000764	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000131	0.000763	CcSEcCtD
Escitalopram—Anorexia—Simvastatin—atherosclerosis	0.000131	0.000761	CcSEcCtD
Escitalopram—Dyspnoea—Lovastatin—atherosclerosis	0.000131	0.000761	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000131	0.00076	CcSEcCtD
Escitalopram—Insomnia—Ezetimibe—atherosclerosis	0.00013	0.000758	CcSEcCtD
Escitalopram—Arthralgia—Pravastatin—atherosclerosis	0.00013	0.000753	CcSEcCtD
Escitalopram—Chest pain—Pravastatin—atherosclerosis	0.00013	0.000753	CcSEcCtD
Escitalopram—Myalgia—Pravastatin—atherosclerosis	0.00013	0.000753	CcSEcCtD
Escitalopram—Paraesthesia—Ezetimibe—atherosclerosis	0.000129	0.000752	CcSEcCtD
Escitalopram—Dyspepsia—Lovastatin—atherosclerosis	0.000129	0.000752	CcSEcCtD
Escitalopram—Anxiety—Pravastatin—atherosclerosis	0.000129	0.000751	CcSEcCtD
Escitalopram—Dry mouth—Niacin—atherosclerosis	0.000129	0.000748	CcSEcCtD
Escitalopram—Dyspnoea—Ezetimibe—atherosclerosis	0.000128	0.000747	CcSEcCtD
Escitalopram—Discomfort—Pravastatin—atherosclerosis	0.000128	0.000744	CcSEcCtD
Escitalopram—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000128	0.000742	CcSEcCtD
Escitalopram—Decreased appetite—Lovastatin—atherosclerosis	0.000128	0.000742	CcSEcCtD
Escitalopram—Dyspepsia—Ezetimibe—atherosclerosis	0.000127	0.000737	CcSEcCtD
Escitalopram—Fatigue—Lovastatin—atherosclerosis	0.000127	0.000736	CcSEcCtD
Escitalopram—Anaphylactic shock—Niacin—atherosclerosis	0.000126	0.000734	CcSEcCtD
Escitalopram—Oedema—Niacin—atherosclerosis	0.000126	0.000734	CcSEcCtD
Escitalopram—Pain—Lovastatin—atherosclerosis	0.000126	0.00073	CcSEcCtD
Escitalopram—Constipation—Lovastatin—atherosclerosis	0.000126	0.00073	CcSEcCtD
Escitalopram—Confusional state—Pravastatin—atherosclerosis	0.000125	0.000728	CcSEcCtD
Escitalopram—Decreased appetite—Ezetimibe—atherosclerosis	0.000125	0.000728	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000125	0.000728	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000124	0.000723	CcSEcCtD
Escitalopram—Asthenia—Rosuvastatin—atherosclerosis	0.000124	0.000723	CcSEcCtD
Escitalopram—Insomnia—Simvastatin—atherosclerosis	0.000124	0.000723	CcSEcCtD
Escitalopram—Oedema—Pravastatin—atherosclerosis	0.000124	0.000722	CcSEcCtD
Escitalopram—Anaphylactic shock—Pravastatin—atherosclerosis	0.000124	0.000722	CcSEcCtD
Escitalopram—Fatigue—Ezetimibe—atherosclerosis	0.000124	0.000722	CcSEcCtD
Escitalopram—Shock—Niacin—atherosclerosis	0.000124	0.000722	CcSEcCtD
Escitalopram—Infection—Pravastatin—atherosclerosis	0.000123	0.000717	CcSEcCtD
Escitalopram—Paraesthesia—Simvastatin—atherosclerosis	0.000123	0.000717	CcSEcCtD
Escitalopram—Pain—Ezetimibe—atherosclerosis	0.000123	0.000716	CcSEcCtD
Escitalopram—Constipation—Ezetimibe—atherosclerosis	0.000123	0.000716	CcSEcCtD
Escitalopram—Tachycardia—Niacin—atherosclerosis	0.000123	0.000716	CcSEcCtD
Escitalopram—Pruritus—Rosuvastatin—atherosclerosis	0.000123	0.000713	CcSEcCtD
Escitalopram—Skin disorder—Niacin—atherosclerosis	0.000122	0.000712	CcSEcCtD
Escitalopram—Dyspnoea—Simvastatin—atherosclerosis	0.000122	0.000712	CcSEcCtD
Escitalopram—Hyperhidrosis—Niacin—atherosclerosis	0.000122	0.000709	CcSEcCtD
Escitalopram—Thrombocytopenia—Pravastatin—atherosclerosis	0.000122	0.000707	CcSEcCtD
Escitalopram—Feeling abnormal—Lovastatin—atherosclerosis	0.000121	0.000704	CcSEcCtD
Escitalopram—Dyspepsia—Simvastatin—atherosclerosis	0.000121	0.000703	CcSEcCtD
Escitalopram—Anorexia—Niacin—atherosclerosis	0.00012	0.000699	CcSEcCtD
Escitalopram—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00012	0.000698	CcSEcCtD
Escitalopram—Hyperhidrosis—Pravastatin—atherosclerosis	0.00012	0.000698	CcSEcCtD
Escitalopram—Decreased appetite—Simvastatin—atherosclerosis	0.000119	0.000694	CcSEcCtD
Escitalopram—Feeling abnormal—Ezetimibe—atherosclerosis	0.000119	0.00069	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000119	0.00069	CcSEcCtD
Escitalopram—Diarrhoea—Rosuvastatin—atherosclerosis	0.000119	0.00069	CcSEcCtD
Escitalopram—Fatigue—Simvastatin—atherosclerosis	0.000118	0.000689	CcSEcCtD
Escitalopram—Anorexia—Pravastatin—atherosclerosis	0.000118	0.000688	CcSEcCtD
Escitalopram—Hypotension—Niacin—atherosclerosis	0.000118	0.000685	CcSEcCtD
Escitalopram—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000118	0.000685	CcSEcCtD
Escitalopram—Constipation—Simvastatin—atherosclerosis	0.000117	0.000683	CcSEcCtD
Escitalopram—Pain—Simvastatin—atherosclerosis	0.000117	0.000683	CcSEcCtD
Escitalopram—Urticaria—Lovastatin—atherosclerosis	0.000117	0.000678	CcSEcCtD
Escitalopram—Body temperature increased—Lovastatin—atherosclerosis	0.000116	0.000675	CcSEcCtD
Escitalopram—Abdominal pain—Lovastatin—atherosclerosis	0.000116	0.000675	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000115	0.000668	CcSEcCtD
Escitalopram—Dizziness—Rosuvastatin—atherosclerosis	0.000115	0.000666	CcSEcCtD
Escitalopram—Urticaria—Ezetimibe—atherosclerosis	0.000114	0.000665	CcSEcCtD
Escitalopram—Insomnia—Niacin—atherosclerosis	0.000114	0.000663	CcSEcCtD
Escitalopram—Abdominal pain—Ezetimibe—atherosclerosis	0.000114	0.000662	CcSEcCtD
Escitalopram—Body temperature increased—Ezetimibe—atherosclerosis	0.000114	0.000662	CcSEcCtD
Escitalopram—Paraesthesia—Niacin—atherosclerosis	0.000113	0.000659	CcSEcCtD
Escitalopram—Feeling abnormal—Simvastatin—atherosclerosis	0.000113	0.000658	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000113	0.000658	CcSEcCtD
Escitalopram—Dyspnoea—Niacin—atherosclerosis	0.000112	0.000654	CcSEcCtD
Escitalopram—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000112	0.000653	CcSEcCtD
Escitalopram—Insomnia—Pravastatin—atherosclerosis	0.000112	0.000653	CcSEcCtD
Escitalopram—Somnolence—Niacin—atherosclerosis	0.000112	0.000652	CcSEcCtD
Escitalopram—Paraesthesia—Pravastatin—atherosclerosis	0.000111	0.000649	CcSEcCtD
Escitalopram—Dyspepsia—Niacin—atherosclerosis	0.000111	0.000646	CcSEcCtD
Escitalopram—Dyspnoea—Pravastatin—atherosclerosis	0.000111	0.000644	CcSEcCtD
Escitalopram—Decreased appetite—Niacin—atherosclerosis	0.00011	0.000638	CcSEcCtD
Escitalopram—Dyspepsia—Pravastatin—atherosclerosis	0.000109	0.000636	CcSEcCtD
Escitalopram—Rash—Rosuvastatin—atherosclerosis	0.000109	0.000635	CcSEcCtD
Escitalopram—Dermatitis—Rosuvastatin—atherosclerosis	0.000109	0.000635	CcSEcCtD
Escitalopram—Urticaria—Simvastatin—atherosclerosis	0.000109	0.000635	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Niacin—atherosclerosis	0.000109	0.000633	CcSEcCtD
Escitalopram—Body temperature increased—Simvastatin—atherosclerosis	0.000109	0.000631	CcSEcCtD
Escitalopram—Abdominal pain—Simvastatin—atherosclerosis	0.000109	0.000631	CcSEcCtD
Escitalopram—Headache—Rosuvastatin—atherosclerosis	0.000109	0.000631	CcSEcCtD
Escitalopram—Hypersensitivity—Lovastatin—atherosclerosis	0.000108	0.000629	CcSEcCtD
Escitalopram—Decreased appetite—Pravastatin—atherosclerosis	0.000108	0.000628	CcSEcCtD
Escitalopram—Pain—Niacin—atherosclerosis	0.000108	0.000627	CcSEcCtD
Escitalopram—Fatigue—Pravastatin—atherosclerosis	0.000107	0.000623	CcSEcCtD
Escitalopram—Pain—Pravastatin—atherosclerosis	0.000106	0.000618	CcSEcCtD
Escitalopram—Constipation—Pravastatin—atherosclerosis	0.000106	0.000618	CcSEcCtD
Escitalopram—Hypersensitivity—Ezetimibe—atherosclerosis	0.000106	0.000617	CcSEcCtD
Escitalopram—Asthenia—Lovastatin—atherosclerosis	0.000105	0.000613	CcSEcCtD
Escitalopram—Pruritus—Lovastatin—atherosclerosis	0.000104	0.000604	CcSEcCtD
Escitalopram—Asthenia—Ezetimibe—atherosclerosis	0.000103	0.000601	CcSEcCtD
Escitalopram—Gastrointestinal pain—Niacin—atherosclerosis	0.000103	0.0006	CcSEcCtD
Escitalopram—Nausea—Rosuvastatin—atherosclerosis	0.000103	0.000599	CcSEcCtD
Escitalopram—Feeling abnormal—Pravastatin—atherosclerosis	0.000102	0.000595	CcSEcCtD
Escitalopram—Pruritus—Ezetimibe—atherosclerosis	0.000102	0.000593	CcSEcCtD
Escitalopram—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000102	0.000591	CcSEcCtD
Escitalopram—Hypersensitivity—Simvastatin—atherosclerosis	0.000101	0.000589	CcSEcCtD
Escitalopram—Diarrhoea—Lovastatin—atherosclerosis	0.0001	0.000584	CcSEcCtD
Escitalopram—Urticaria—Niacin—atherosclerosis	0.0001	0.000583	CcSEcCtD
Escitalopram—Abdominal pain—Niacin—atherosclerosis	9.97e-05	0.00058	CcSEcCtD
Escitalopram—Body temperature increased—Niacin—atherosclerosis	9.97e-05	0.00058	CcSEcCtD
Escitalopram—Urticaria—Pravastatin—atherosclerosis	9.86e-05	0.000574	CcSEcCtD
Escitalopram—Asthenia—Simvastatin—atherosclerosis	9.85e-05	0.000573	CcSEcCtD
Escitalopram—Diarrhoea—Ezetimibe—atherosclerosis	9.85e-05	0.000573	CcSEcCtD
Escitalopram—Abdominal pain—Pravastatin—atherosclerosis	9.82e-05	0.000571	CcSEcCtD
Escitalopram—Body temperature increased—Pravastatin—atherosclerosis	9.82e-05	0.000571	CcSEcCtD
Escitalopram—Pruritus—Simvastatin—atherosclerosis	9.72e-05	0.000565	CcSEcCtD
Escitalopram—Dizziness—Lovastatin—atherosclerosis	9.71e-05	0.000565	CcSEcCtD
Escitalopram—Dizziness—Ezetimibe—atherosclerosis	9.52e-05	0.000554	CcSEcCtD
Escitalopram—Diarrhoea—Simvastatin—atherosclerosis	9.4e-05	0.000547	CcSEcCtD
Escitalopram—Vomiting—Lovastatin—atherosclerosis	9.34e-05	0.000543	CcSEcCtD
Escitalopram—Hypersensitivity—Niacin—atherosclerosis	9.29e-05	0.00054	CcSEcCtD
Escitalopram—Rash—Lovastatin—atherosclerosis	9.26e-05	0.000538	CcSEcCtD
Escitalopram—Dermatitis—Lovastatin—atherosclerosis	9.25e-05	0.000538	CcSEcCtD
Escitalopram—Headache—Lovastatin—atherosclerosis	9.2e-05	0.000535	CcSEcCtD
Escitalopram—Vomiting—Ezetimibe—atherosclerosis	9.16e-05	0.000533	CcSEcCtD
Escitalopram—Hypersensitivity—Pravastatin—atherosclerosis	9.15e-05	0.000532	CcSEcCtD
Escitalopram—Dizziness—Simvastatin—atherosclerosis	9.08e-05	0.000528	CcSEcCtD
Escitalopram—Rash—Ezetimibe—atherosclerosis	9.08e-05	0.000528	CcSEcCtD
Escitalopram—Dermatitis—Ezetimibe—atherosclerosis	9.07e-05	0.000528	CcSEcCtD
Escitalopram—Asthenia—Niacin—atherosclerosis	9.05e-05	0.000526	CcSEcCtD
Escitalopram—Headache—Ezetimibe—atherosclerosis	9.02e-05	0.000525	CcSEcCtD
Escitalopram—Pruritus—Niacin—atherosclerosis	8.92e-05	0.000519	CcSEcCtD
Escitalopram—Asthenia—Pravastatin—atherosclerosis	8.91e-05	0.000518	CcSEcCtD
Escitalopram—Pruritus—Pravastatin—atherosclerosis	8.79e-05	0.000511	CcSEcCtD
Escitalopram—Vomiting—Simvastatin—atherosclerosis	8.73e-05	0.000508	CcSEcCtD
Escitalopram—Nausea—Lovastatin—atherosclerosis	8.72e-05	0.000507	CcSEcCtD
Escitalopram—Rash—Simvastatin—atherosclerosis	8.66e-05	0.000504	CcSEcCtD
Escitalopram—Dermatitis—Simvastatin—atherosclerosis	8.65e-05	0.000503	CcSEcCtD
Escitalopram—Diarrhoea—Niacin—atherosclerosis	8.63e-05	0.000502	CcSEcCtD
Escitalopram—Headache—Simvastatin—atherosclerosis	8.6e-05	0.0005	CcSEcCtD
Escitalopram—Nausea—Ezetimibe—atherosclerosis	8.55e-05	0.000498	CcSEcCtD
Escitalopram—Diarrhoea—Pravastatin—atherosclerosis	8.5e-05	0.000494	CcSEcCtD
Escitalopram—Dizziness—Niacin—atherosclerosis	8.34e-05	0.000485	CcSEcCtD
Escitalopram—Dizziness—Pravastatin—atherosclerosis	8.21e-05	0.000478	CcSEcCtD
Escitalopram—Nausea—Simvastatin—atherosclerosis	8.16e-05	0.000474	CcSEcCtD
Escitalopram—Vomiting—Niacin—atherosclerosis	8.02e-05	0.000466	CcSEcCtD
Escitalopram—Rash—Niacin—atherosclerosis	7.95e-05	0.000462	CcSEcCtD
Escitalopram—Dermatitis—Niacin—atherosclerosis	7.94e-05	0.000462	CcSEcCtD
Escitalopram—Headache—Niacin—atherosclerosis	7.9e-05	0.00046	CcSEcCtD
Escitalopram—Vomiting—Pravastatin—atherosclerosis	7.9e-05	0.000459	CcSEcCtD
Escitalopram—Rash—Pravastatin—atherosclerosis	7.83e-05	0.000455	CcSEcCtD
Escitalopram—Dermatitis—Pravastatin—atherosclerosis	7.82e-05	0.000455	CcSEcCtD
Escitalopram—Headache—Pravastatin—atherosclerosis	7.78e-05	0.000452	CcSEcCtD
Escitalopram—Nausea—Niacin—atherosclerosis	7.49e-05	0.000436	CcSEcCtD
Escitalopram—Nausea—Pravastatin—atherosclerosis	7.38e-05	0.000429	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—CCL2—atherosclerosis	8.1e-06	0.000196	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EDN1—atherosclerosis	8.08e-06	0.000196	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	8.08e-06	0.000195	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LCAT—atherosclerosis	8.08e-06	0.000195	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FABP4—atherosclerosis	8.08e-06	0.000195	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLG—atherosclerosis	8.05e-06	0.000195	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLG—atherosclerosis	8.02e-06	0.000194	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL5—atherosclerosis	8.02e-06	0.000194	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NAMPT—atherosclerosis	7.96e-06	0.000193	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	7.95e-06	0.000192	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SCARB1—atherosclerosis	7.95e-06	0.000192	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA4—atherosclerosis	7.93e-06	0.000192	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LIPC—atherosclerosis	7.91e-06	0.000191	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLG—atherosclerosis	7.9e-06	0.000191	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOC3—atherosclerosis	7.86e-06	0.00019	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LPL—atherosclerosis	7.84e-06	0.00019	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LDLR—atherosclerosis	7.82e-06	0.000189	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.79e-06	0.000188	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.74e-06	0.000187	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CETP—atherosclerosis	7.63e-06	0.000185	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	7.63e-06	0.000185	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SOCS3—atherosclerosis	7.62e-06	0.000184	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	7.6e-06	0.000184	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.51e-06	0.000182	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	7.48e-06	0.000181	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SPP1—atherosclerosis	7.43e-06	0.00018	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	7.39e-06	0.000179	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP3—atherosclerosis	7.36e-06	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP3—atherosclerosis	7.34e-06	0.000178	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF2—atherosclerosis	7.33e-06	0.000177	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.31e-06	0.000177	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF2—atherosclerosis	7.31e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	7.23e-06	0.000175	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.2e-06	0.000174	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	7.19e-06	0.000174	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOB—atherosclerosis	7.12e-06	0.000172	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOB—atherosclerosis	7.09e-06	0.000172	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	7.06e-06	0.000171	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	7.03e-06	0.00017	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EDN1—atherosclerosis	7e-06	0.000169	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOB—atherosclerosis	6.98e-06	0.000169	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EDN1—atherosclerosis	6.98e-06	0.000169	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL5—atherosclerosis	6.95e-06	0.000168	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL5—atherosclerosis	6.93e-06	0.000168	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	6.92e-06	0.000168	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.9e-06	0.000167	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	6.87e-06	0.000166	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	6.87e-06	0.000166	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.83e-06	0.000165	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.83e-06	0.000165	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA2—atherosclerosis	6.83e-06	0.000165	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.83e-06	0.000165	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	6.82e-06	0.000165	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LPL—atherosclerosis	6.8e-06	0.000164	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LPL—atherosclerosis	6.77e-06	0.000164	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.77e-06	0.000164	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.74e-06	0.000163	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AGT—atherosclerosis	6.71e-06	0.000162	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.69e-06	0.000162	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LPL—atherosclerosis	6.67e-06	0.000161	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCG—atherosclerosis	6.61e-06	0.00016	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	6.59e-06	0.000159	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—atherosclerosis	6.57e-06	0.000159	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—atherosclerosis	6.57e-06	0.000159	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CAV1—atherosclerosis	6.51e-06	0.000158	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPA—atherosclerosis	6.51e-06	0.000158	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOA1—atherosclerosis	6.5e-06	0.000157	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	6.48e-06	0.000157	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SPP1—atherosclerosis	6.44e-06	0.000156	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SPP1—atherosclerosis	6.42e-06	0.000155	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	6.41e-06	0.000155	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	6.39e-06	0.000155	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	6.32e-06	0.000153	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BGN—atherosclerosis	6.31e-06	0.000153	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	6.29e-06	0.000152	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ESR1—atherosclerosis	6.28e-06	0.000152	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA5—atherosclerosis	6.24e-06	0.000151	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—F2—atherosclerosis	6.2e-06	0.00015	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.15e-06	0.000149	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.01e-06	0.000145	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDGFB—atherosclerosis	5.96e-06	0.000144	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	5.94e-06	0.000144	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	5.93e-06	0.000144	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	5.84e-06	0.000141	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AGT—atherosclerosis	5.81e-06	0.000141	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.8e-06	0.00014	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—atherosclerosis	5.79e-06	0.00014	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.74e-06	0.000139	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—atherosclerosis	5.7e-06	0.000138	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—atherosclerosis	5.7e-06	0.000138	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—atherosclerosis	5.7e-06	0.000138	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	5.68e-06	0.000137	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—atherosclerosis	5.68e-06	0.000137	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—atherosclerosis	5.68e-06	0.000137	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CAV1—atherosclerosis	5.64e-06	0.000137	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—atherosclerosis	5.63e-06	0.000136	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CAV1—atherosclerosis	5.63e-06	0.000136	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—atherosclerosis	5.62e-06	0.000136	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—atherosclerosis	5.61e-06	0.000136	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—atherosclerosis	5.59e-06	0.000135	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—atherosclerosis	5.59e-06	0.000135	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	5.54e-06	0.000134	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	5.53e-06	0.000134	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—atherosclerosis	5.53e-06	0.000134	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOB—atherosclerosis	5.5e-06	0.000133	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—atherosclerosis	5.44e-06	0.000132	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—atherosclerosis	5.43e-06	0.000131	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—atherosclerosis	5.42e-06	0.000131	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—atherosclerosis	5.37e-06	0.00013	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—atherosclerosis	5.35e-06	0.00013	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.35e-06	0.000129	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	5.34e-06	0.000129	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.28e-06	0.000128	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—atherosclerosis	5.27e-06	0.000128	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—atherosclerosis	5.25e-06	0.000127	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.21e-06	0.000126	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—atherosclerosis	5.17e-06	0.000125	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	5.16e-06	0.000125	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOC3—atherosclerosis	5.14e-06	0.000124	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	5.14e-06	0.000124	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.12e-06	0.000124	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—atherosclerosis	5.12e-06	0.000124	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LDLR—atherosclerosis	5.11e-06	0.000124	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOB—atherosclerosis	5.06e-06	0.000122	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	5.04e-06	0.000122	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CETP—atherosclerosis	4.99e-06	0.000121	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD36—atherosclerosis	4.99e-06	0.000121	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—atherosclerosis	4.92e-06	0.000119	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	4.92e-06	0.000119	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.92e-06	0.000119	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	4.91e-06	0.000119	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—atherosclerosis	4.87e-06	0.000118	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—atherosclerosis	4.85e-06	0.000117	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	4.83e-06	0.000117	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—atherosclerosis	4.83e-06	0.000117	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—atherosclerosis	4.79e-06	0.000116	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.78e-06	0.000116	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—atherosclerosis	4.77e-06	0.000116	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—atherosclerosis	4.77e-06	0.000115	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.73e-06	0.000114	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—atherosclerosis	4.71e-06	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—atherosclerosis	4.71e-06	0.000114	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	4.7e-06	0.000114	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—atherosclerosis	4.69e-06	0.000114	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—atherosclerosis	4.64e-06	0.000112	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	4.62e-06	0.000112	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD36—atherosclerosis	4.59e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.51e-06	0.000109	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—atherosclerosis	4.49e-06	0.000109	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	4.47e-06	0.000108	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.46e-06	0.000108	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—atherosclerosis	4.4e-06	0.000106	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	4.39e-06	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	4.37e-06	0.000106	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAV1—atherosclerosis	4.36e-06	0.000105	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—atherosclerosis	4.35e-06	0.000105	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.35e-06	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.27e-06	0.000103	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—atherosclerosis	4.26e-06	0.000103	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.25e-06	0.000103	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	4.22e-06	0.000102	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	4.19e-06	0.000101	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—atherosclerosis	4.15e-06	0.000101	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—atherosclerosis	4.13e-06	9.99e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—atherosclerosis	4.05e-06	9.79e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.02e-06	9.73e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAV1—atherosclerosis	4.01e-06	9.7e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—atherosclerosis	4e-06	9.68e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.97e-06	9.61e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—atherosclerosis	3.95e-06	9.56e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	3.91e-06	9.46e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	3.84e-06	9.3e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—atherosclerosis	3.83e-06	9.27e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	3.83e-06	9.27e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.79e-06	9.16e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	3.77e-06	9.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—atherosclerosis	3.76e-06	9.1e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	3.71e-06	8.99e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.66e-06	8.85e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.65e-06	8.84e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.64e-06	8.82e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.6e-06	8.71e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3.59e-06	8.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.59e-06	8.68e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	3.55e-06	8.58e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.53e-06	8.55e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—atherosclerosis	3.53e-06	8.53e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—atherosclerosis	3.51e-06	8.5e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—atherosclerosis	3.46e-06	8.37e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.45e-06	8.35e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—atherosclerosis	3.45e-06	8.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.42e-06	8.28e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.41e-06	8.26e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.39e-06	8.2e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.38e-06	8.17e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	3.36e-06	8.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	3.36e-06	8.12e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.33e-06	8.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	3.32e-06	8.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.32e-06	8.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.32e-06	8.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.31e-06	8.01e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOB—atherosclerosis	3.31e-06	8e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—atherosclerosis	3.3e-06	7.98e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	3.27e-06	7.91e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	3.26e-06	7.88e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	3.26e-06	7.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.22e-06	7.78e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—atherosclerosis	3.17e-06	7.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—atherosclerosis	3.16e-06	7.64e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—atherosclerosis	3.08e-06	7.45e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—atherosclerosis	3.07e-06	7.44e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.06e-06	7.41e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—atherosclerosis	3.04e-06	7.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.03e-06	7.34e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—atherosclerosis	3.03e-06	7.34e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	3.02e-06	7.3e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.01e-06	7.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD36—atherosclerosis	3e-06	7.26e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	2.99e-06	7.23e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.91e-06	7.04e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	2.9e-06	7.01e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	2.85e-06	6.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.84e-06	6.88e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.82e-06	6.83e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.81e-06	6.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—atherosclerosis	2.79e-06	6.75e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.77e-06	6.71e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	2.77e-06	6.7e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—atherosclerosis	2.7e-06	6.53e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—atherosclerosis	2.65e-06	6.4e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAV1—atherosclerosis	2.62e-06	6.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—atherosclerosis	2.62e-06	6.33e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—atherosclerosis	2.45e-06	5.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.39e-06	5.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—atherosclerosis	2.3e-06	5.58e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2.26e-06	5.48e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—atherosclerosis	2.26e-06	5.47e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—atherosclerosis	2.13e-06	5.14e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.12e-06	5.13e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.09e-06	5.05e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—atherosclerosis	2.07e-06	5.01e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—atherosclerosis	1.98e-06	4.8e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.96e-06	4.75e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.96e-06	4.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.92e-06	4.66e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.81e-06	4.39e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—atherosclerosis	1.52e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—atherosclerosis	1.39e-06	3.37e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—atherosclerosis	9.11e-07	2.2e-05	CbGpPWpGaD
